tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Joseph Catanzaro, 325 are a BUY (78.69%), 88 are a HOLD (21.31%).
Analyst Joseph Catanzaro, currently employed at MIZUHO, carries an average stock price target met ratio of 48.4% that have a potential upside of 36.99% achieved within 144 days. Previously, Joseph Catanzaro worked at PIPER SANDLER.
Joseph Catanzaro’s has documented 811 price targets and ratings displayed on 59 stocks. The coverage is on Healthcare, Consumer Cyclical, Industrials, Consumer Defensive sectors.
Most recent stock forecast was given on BCAX, Bicara Therapeutics Common Stock at 12-Aug-2026.
Analyst best performing recommendations are on CLVS (CLOVIS ONCOLOGY).
The best stock recommendation documented was for CTMX (CYTOMX THERAPEUTICS) at 4/14/2025. The price target of $2.5 was fulfilled within 29 days with a profit of $1.89 (309.84%) receiving and performance score of 106.84.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 08-Sep-2021
$1.75
$-0.27 (-13.37%)
2 years 1 months 9 days ago
(27-Aug-2024)
1/4 (25%)
$0.07 (4.17%)
2
Buy Since 12-Jan-2022
$1.5
$-0.52 (-25.74%)
2 years 1 months 15 days ago
(21-Aug-2024)
0/2 (0%)
$-0.05 (-3.23%)
Hold Since 14-May-2024
2 years 1 months 15 days ago
(21-Aug-2024)
0/5 (0%)
$37.88 (532.02%)
Buy Since 30-Aug-2021
$49
$46.98 (2325.74%)
4 years 10 months 5 days ago
(01-Dec-2021)
0/3 (0%)
$28.91 (143.90%)
Buy Since 30-Aug-2021
$49
$46.98 (2325.74%)
4 years 10 months 5 days ago
(01-Dec-2021)
2/4 (50%)
$28.91 (143.90%)
82
Which stock is Joseph Catanzaro most bullish on?
Which stock is Joseph Catanzaro most reserved on?
What Year was the first public recommendation made by Joseph Catanzaro?
